Adaptix secures US federal route for portable 3D imaging

Avingtrans plc

Avingtrans subsidiary Adaptix has appointed Spartan Medical as the exclusive US federal government reseller of its Ortho350 portable 3D imaging system.

The agreement gives Adaptix a direct route into Department of Veterans Affairs medical centres, military treatment facilities and other federal healthcare organisations.

Spartan Medical is a Service-Disabled Veteran-Owned Small Business with experience in federal healthcare procurement. Its role is to support access to a market where purchasing processes can be complex and sales cycles can be long. Using an established federal reseller reduces the need for Adaptix to build its own government sales infrastructure. It also gives the company a partner that understands the requirements of Veterans Affairs and Department of Defense facilities.

The Ortho350 is designed to provide 3D orthopaedic imaging at the point of care. It can produce CT-style images in an examination room in under 20 seconds, using a radiation dose comparable with conventional plain-film imaging.

This allows clinicians to access more detailed images without sending patients to a separate CT facility. The system may be useful in locations where space, cost or infrastructure limits access to conventional scanners.

Adaptix uses low-dose tomosynthesis technology to create high-resolution 3D images of bone structures and soft tissue. The company says the system can improve diagnostic visibility while reducing radiation exposure and operating costs compared with traditional CT imaging.

Avingtrans plc (LON:AVG) has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. 

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Adaptix secures US federal route for portable 3D imaging

Adaptix has appointed Spartan Medical as the exclusive US federal reseller of its portable Ortho350 3D imaging system.

Avingtrans Raises £21 Million to Expand Its US Nuclear Opportunity, Cavendish

Avingtrans secures £21 million to expand US nuclear capacity, supporting forecast growth, stronger margins and Cavendish’s increased target price outlook.

Avingtrans launches proposed placing to support corporate funding

Avingtrans plc has announced a proposed placing, with the announcement initially accompanied by standard securities offering disclaimers.

Booth Industries builds rail infrastructure credibility with HS1 safety systems

Booth Industries’ HS1 project shows its ability to deliver certified safety systems for critical rail infrastructure with long-term reliability.

Avingtrans reports FY26 profit in line with expectations

Avingtrans says profit for the year will be in line with expectations, with further contract wins across nuclear, infrastructure and imaging markets.

UK quantum strategy highlights opportunity for specialist magnet systems

UK plans to scale quantum computing highlight the role of specialist superconducting magnet systems in supporting the sector’s move towards commercial deployment.

Search